Valeant Pharmaceuticals International is selling plants in Puerto Rico and Switzerland in what the Aliso Viejo drug maker calls the last part of a long restructuring.
Legacy Pharmaceuticals International GMBH, a Swiss drug maker, is buying the plants from Valeant. The deal also includes Valeant’s Reptilase drug, which is used to control bleeding.
Terms of the deal weren’t disclosed.
The deal “represents the final step in our restructuring initiative,” Chief Executive Tim Tyson said.
In the past few years, Valeant has sold plants, products, and in March, its longtime headquarters in Costa Mesa. The company moved to Aliso Viejo last year.
The moves are part of a restructuring started after the 2002 ouster by shareholders of former chief executive and founder Milan Panic, who expanded the company into scores of products and various regions, including his native Eastern Europe.
